Zinzinos, Insider

Zinzino's Insider Trading Signals Clash With Record-Breaking Sales Momentum

Published on 09/08/2026 at 03:30 | Editorial boerse-global.de

Zinzino's August sales rose 15% to SEK 282.2M, but insider selling and a 21% share drop spark valuation concerns.

Zinzino Sales Surge 15% in August, Yet Insider Sales and Share Slump Raise Doubts
Zinzino ABries B Illustration mit AI erstellt.

The Swedish direct-sales group Zinzino AB finds itself in an unusual position: its operational engine is firing on all cylinders, yet its share price tells a decidedly more cautious story. August sales figures released last Thursday showed group revenue climbing to SEK 282.2 million, a 15 percent improvement over the same month last year, extending a run that has seen the company compound growth month after month.

That momentum shows no signs of abating over the longer horizon. For the first eight months of 2026, cumulative revenue reached SEK 2,464.8 million, up 22 percent year-on-year. The core sales market segment delivered the heavy lifting in August, advancing 16 percent to SEK 280.9 million, while the Faun Pharma subsidiary contributed just SEK 1.3 million in external revenue — a reminder of where the group's strategic priorities now lie.

Divergent Insider Activity Raises Eyebrows

Yet it is the insider trading patterns that have captured investor attention in recent sessions. Finn Ørjan Saele, the company's co-founder, has been accumulating shares worth roughly SEK 2.1 million, a move typically interpreted as a vote of confidence in the long-term strategy. But that buying has been countered by a wave of selling from other senior figures.

Chairman Hans Jacobsson disposed of 13,153 B-shares last Tuesday for approximately SEK 1.9 million, according to the Swedish financial supervisory authority's register. That followed late-August transactions by CEO Dag Bergheim Pettersen, who trimmed his position through sales totalling around SEK 14.3 million. The contrasting signals — a founder buying while the chairman and chief executive reduce their exposure — have left market participants weighing whether the insider activity reflects personal portfolio management or something more fundamental.

Should investors sell immediately? Or is it worth buying Zinzino ABries B?

The Valuation Puzzle

The equity currently trades at roughly €12.54, having slipped 1.9 percent in the previous session, and sits 21 percent lower than twelve months ago. That disconnect between double-digit revenue expansion and a declining share price has become the central question for Zinzino watchers: is the market failing to price in sustained growth, or are other factors weighing on the multiple?

The second-quarter report, published around two weeks ago, offered little clarity on that front. Revenue rose 18 percent to SEK 936.8 million — or 23 percent in local currencies — while EBITDA reached SEK 153.1 million, representing a margin of 16.3 percent. Operating cash flow came in at SEK 280.0 million, and first-half net profit stood at SEK 210.4 million. Despite that robust set of numbers, the stock has shed approximately 4.8 percent since the release, a reaction that hints at lingering scepticism about the durability of the growth trajectory.

South American Expansion and Strategic Investments

Operationally, the company continues to broaden its geographic footprint. The second quarter saw the opening of a new official market in Colombia, marking Zinzino's entry into South America, alongside the introduction of an AI-powered customer support tool. Both initiatives reflect a dual strategy of diversifying the direct-selling business across new territories while enhancing service efficiency through technology.

The balance sheet provides ample firepower for further expansion: liquid assets stood at SEK 842.0 million at the end of the reporting period, offering considerable headroom for additional market entries and product development.

What Lies Ahead

Investors now face a waiting game until November 17, 2026, when the company is scheduled to release its third-quarter figures. Between now and then, the interplay between the operational growth narrative and the mixed insider signals will likely remain the dominant theme for those tracking the stock. The August performance suggests the business itself is in rude health — whether that translates into shareholder returns will depend on how the market chooses to interpret the competing messages emanating from the company's leadership.

Ad

Zinzino ABries B Stock: New Analysis - 8 September

Fresh Zinzino ABries B information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated Zinzino ABries B analysis...

Disclaimer...

en | SE0002480442 | ZINZINOS | boerse | 70066189 |